Pre-Clinical Package for Small Molecules
Identifying Candidates and Highlighting Potential Pitfalls
Our pre-clinical package for small molecules offers an intelligent, rapid, and economical approach for lead identification. Designed to identify candidates with drug product-like characteristics, it will also highlight the potential pitfalls associated with the molecules.
Experimental efforts concentrate on establishing the physical / chemical, solubility, stability and polymorphic characteristics of each candidate. The information generated can then be used to make a rational decision for lead identification.
Timelines and Costs
It is anticipated that the pre-clinical package will be completed in 4 weeks. Typically, we customise studies to our clients’ needs and budget. Quotations are available on request.